STEPHANIE WILLIAMS: Open Payments
NPI 1093206591 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,453 in 43 payments from 8 companies in 2025. Trend: 2023 $1,954 · 2024 $2,551 · 2025 $1,453
Food & beverage: $1,447Education: $5
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 9 | $333 |
| Teva Pharmaceuticals USA, Inc. | 10 | $327 |
| Janssen Pharmaceuticals, Inc | 8 | $317 |
| E.R. Squibb & Sons, L.L.C. | 9 | $219 |
| Vanda Pharmaceuticals Inc. | 1 | $117 |
| Lundbeck LLC | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| ABBVIE INC. | 1 | $30 |
Products named: INGREZZA, UZEDY, COBENFY, INVEGA SUSTENNA, SPRAVATO, FANAPT, ABILIFY MAINTENA, AUSTEDO XR.
Industry payments across GA — which companies pay providers there.
